000 01359 a2200361 4500
005 20250517140724.0
264 0 _c20170315
008 201703s 0 0 eng d
022 _a1536-5964
024 7 _a10.1097/MD.0000000000006151
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYuan, Jin-Qiu
245 0 0 _aEGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.
_h[electronic resource]
260 _bMedicine
_cFeb 2017
300 _ae6151 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aErbB Receptors
_xblood
650 0 4 _aHematologic Tests
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSurvival Analysis
650 0 4 _aSystematic Reviews as Topic
650 0 4 _aMeta-Analysis as Topic
700 1 _aZhang, Yue-Lun
700 1 _aLi, Hai-Tao
700 1 _aMao, Chen
773 0 _tMedicine
_gvol. 96
_gno. 7
_gp. e6151
856 4 0 _uhttps://doi.org/10.1097/MD.0000000000006151
_zAvailable from publisher's website
999 _c26886616
_d26886616